Develops research, programs, and initiatives designed to envision and activate sustainable solutions leading to better health for individuals and communities worldwide.
Sarah Wells Kocsis is a director, Public Health, at the Milken Institute, where she leads a portf
olio of work focused on prevention, chronic disease, infrastructure, and other timely issues that are critical to advancing the role of public health in sup
As we members of the biopharmaceutical industry look to the post-COVID-19 world, we can draw lesso
ns from both the successes and failures of the world’s responses to this global crisis. , An innovative therapy is no good to a patient who cannot access it.
,
Addressing deficits in collaboration and access is essential to resolving global challenges that are relevant well beyond COVID-19 to other public health issues including prevalent diseases such as cancer.